These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 6516292

  • 21. Purification and properties of guinea pig antithrombin III.
    Heck L, Rosenberg R, Remold H.
    Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Commercial antithrombin concentrate contains inactive L-forms of antithrombin.
    Chang WS, Harper PL.
    Thromb Haemost; 1997 Feb; 77(2):323-8. PubMed ID: 9157590
    [Abstract] [Full Text] [Related]

  • 27. Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.
    Wolf M, Boyer C, Tripodi A, Meyer D, Larrieu MJ, Mannucci PM.
    Blood; 1985 Feb; 65(2):496-500. PubMed ID: 3967090
    [Abstract] [Full Text] [Related]

  • 28. Studies of the heterogeneity of antithrombin III concentrates.
    Barrowcliffe TW, Eggleton CA, Mahmoud M.
    Br J Haematol; 1983 Sep; 55(1):37-46. PubMed ID: 6882687
    [Abstract] [Full Text] [Related]

  • 29. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
    Aiach M, François D, Priollet P, Capron L, Roncato M, Alhenc-Gelas M, Fiessinger JN.
    Br J Haematol; 1987 Aug; 66(4):515-22. PubMed ID: 3663508
    [Abstract] [Full Text] [Related]

  • 30. Preparation of three types of heparin-sepharose and their binding activities to thrombin and antithrombin III.
    Funahashi M, Matsumoto I, Seno N.
    Anal Biochem; 1982 Nov 01; 126(2):414-21. PubMed ID: 7158775
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Capillary affinity chromatography and affinity capillary electrophoresis of heparin binding proteins.
    Wu X, Linhardt RJ.
    Electrophoresis; 1998 Nov 01; 19(15):2650-3. PubMed ID: 9848674
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Heterogeneity of the "classical" antithrombin III deficiency.
    Sas G, Petö I, Bánhegyi D, Blaskó G, Domján G.
    Thromb Haemost; 1980 Jun 18; 43(2):133-6. PubMed ID: 7455972
    [Abstract] [Full Text] [Related]

  • 37. Recovery of antithrombin III from milk by expanded bed chromatography.
    Ozyurt S, Kirdar B, Ulgen KO.
    J Chromatogr A; 2002 Jan 25; 944(1-2):203-10. PubMed ID: 11831754
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.
    Lane DA, Lowe GD, Flynn A, Thompson E, Ireland H, Erdjument H.
    Br J Haematol; 1987 Aug 25; 66(4):523-7. PubMed ID: 3663509
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.